After promising not to withhold government information over "speculative or abstract fears," the Obama administration has concluded it will not publicly disclose federal records that could shed light on the security of the government's health care website because doing so could "potentially" allow hackers to break in.
Two Northwestern University scientists have identified a biomarker strongly associated with...
British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation...
Warfarin, the longtime standard for atrial fibrillation, is facing competition from new options...
As the nation's drug czar continues to warn people about the potential death and destruction from substance abuse, he's also encouraging them to tell their stories about treatment and recovery. Usually he starts with himself.
An experimental drug saved monkeys from a virus closely related to Ebola even after symptoms began, Texas researchers reported Wednesday. A drug that targets Ebola in the same way is under development, and the study raises questions about how late after infection treatments might work.
The currently available century-old vaccine Bacille Calmette-Guerin, or BCG, provides only partial protection against both tuberculosis and leprosy, so a more potent vaccine is needed to combat both diseases. UCLA-led research may have found a stronger weapon against both diseases.
Ebola-affected countries should immediately begin exit screening all passengers leaving international airports, sea ports and major ground crossings, the U.N. health agency said.
Bristol-Myers Squibb Company and Celgene Corporation announced the establishment of a clinical trial collaboration to evaluate a combination regimen of Bristol-Myers Squibb’s PD-1 immune checkpoint inhibitor, OPDIVO (nivolumab), and Celgene’s chemotherapy ABRAXANE ® (paclitaxel protein-bound particles for injectable suspension), in a Phase I study.
Ipsen announced that Cynthia Schwalm has been named President and CEO of Ipsen N.A., responsible for all commercial and medical affairs operations throughout the region.
The QPix™ 400 series of microbial colony pickers offers the unique option to simultaneously detect colonies and quantify fluorescent markers in a pre-screening step before picking.
Work by scientists at the Universities of Manchester and Auckland suggest that both major forms of diabetes, type-1 and type-2, are the result of the same mechanism.
Genzyme, a Sanofi company, announced that the U.S. Food and Drug Administration has approved Cerdelga™ (eliglustat) capsules, the only first-line oral therapy for certain adult Gaucher disease type 1 patients.
The new Vent-Box ductless filtration system is designed to protect laboratory personnel from chemical vapors found inside of stand alone chemical safety cabinets.
New research shows that major strides are being made in the battle against heart disease and stroke. A recent study shows that patients are going to greater lengths to prevent the onset of these deadly health issues.
The company said Friday that the Food and Drug Administration cleared the injectable drug, dubbed Plegridy, after reviewing results from a study that involved more than 1,500 people with the disease.
Actavis plc (NYSE: ACT) confirmed positive topline results from RECLAIM-1 and -2, pivotal Phase III studies evaluating the potential for the investigational antibiotic, ceftazidime-avibactam as a treatment for adult hospitalized patients with complicated intra-abdominal infections.
Emergency physicians should expect an upswing in what on the surface appear to be heroin overdoses, but are actually overdoses tied to acetyl fentanyl, an opiate that is mixed into street drugs marketed as heroin.
The national airline of the United Arab Emirates said Monday it has disinfected one of its planes after health authorities there announced that a Nigerian woman who died after flying in to the capital, Abu Dhabi, may have been infected with the Ebola virus.